{"slideshow_credits": null, "snippet": "Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients\u2019 reach.", "abstract": "Turing Pharmaceuticals founder Martin Shkreli plans to sharply increase price of drug treating Chagas disease, parasitic infection that can lead to potentially lethal heart problems; company will seek Food and Drug Administration approval for drug already in use in some countries and try to cash in with federal voucher intended to encourage research.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/12/12/business/martin-shkrelis-latest-plan-to-sharply-raise-drug-price-prompts-outcry.html", "lead_paragraph": "Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients\u2019 reach.", "headline": {"main": "Martin Shkreli\u2019s Latest Plan to Sharply Raise Drug Price Prompts Outcry", "print_headline": "Turing Moves to Next Drug "}, "_id": "566b65ad38f0d804c3f4bcbb", "word_count": "1362", "multimedia": [{"height": 126, "url": "images/2015/12/12/business/12chagas-web1/12chagas-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/12/12/business/12chagas-web1/12chagas-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/12/12/business/12chagas-web1/12chagas-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/12/12/business/12chagas-web1/12chagas-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/12/12/business/12chagas-web1/12chagas-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/12/12/business/12chagas-web1/12chagas-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-12-12T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Chagas Disease", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "Y", "rank": "3"}, {"name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Centers for Disease Control and Prevention", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Drugs for Neglected Diseases Initiative", "is_major": "N", "rank": "7"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "8"}, {"name": "glocations", "value": "Latin America", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": null, "type_of_material": "News"}